Glad to see more and more folks recognizing and taking advantage of the TRADING (not investing) opportunities here w/SCRC. Those who are long-timers have seen for the past couple of years that SCRC has been a veritable ATM machine for those who were not naive enough to fall for the horrible conflict-of-interest-filled pumps by the criminal homophobe JOSEPH ZAMPETTI and his legion of fellow CORE members who relentlessly urge others to only buy/add/hold and actively discourage ever selling or trading.
As 2014 was coming to a close, SCRC was well on its way from being a stock with only a "trading thesis" to a stock with BOTH a "trading thesis" and an "investment thesis".
However, as Q1'15 unfolded, we began to see SCRC's fundamentals fall apart. It's golden goose which comprised almost 100% of its revenues, lost CVS/Caremark, the 2nd largest pharmacy benefits manager in the country, and based on the piddly $1.45M in approved orders PR'd for MAR, it would seem that CVS/Caremark apparently accounted for anywhere between 70-80% of SCRC's revenues. Remember, in MAR, the annual beginning-of-year re-setting of deductibles is no longer an issue, so EVEN WITH the uptick due to deductibles no longer being an issue, we still only saw $1.45M for MAR.
In addition, the much hyped PIMD apparently also fell on its face -- so badly that BS Schneiderman didn't even PR MAR revenues. However, we were able to reverse-engineer this number based upon the $912k total Q1'15 number he included in the recently published Investor Presentation deck. Based on $912k for the entire Q1'15 period, after knowing JAN and FEB to be $137k and $554k, respectively, MAR must therefore be only $221k, a decline of over 60% in only its 3rd month of operations.
In addition, the much hyped $4M LOC is virtually non-existent and unavailable due to the drastically decreased A/R balance. Remember, the amount of the LOC that SCRC can actually tap into is capped at 85% of Main Ave's A/R balance.
In addition, the NT filing gave us a glimpse of what the 10K will report, and so we can expect that the upcoming 10K will reflect that while SCRC made a profit in Q3'14, that it somehow managed to increase approved orders by almost $2M in Q4'14 comapred to Q3'14 but yet somehow managed to LOSE MONEY in Q4'14 while operating in one of the highest margin business segments on the planet.
Meaningful good news can certainly improve the company's fundamentals, but at this time nothing is really "expected".
Happy trading folks. Nothing wrong with speculating or hopping on a bandwagon when the indicators signal a high probability (though no guarantees, of course) of a likely move up. There has always been plenty of money to be made here at SCRC with plenty to go around -- just be aware that there are scores of members of the CORE group (many who have publicly self-disclosed their membership) who want it all for themselves and have shown a willingness to lie, cheat, steal, and violate securities fraud laws to stick their hands in everyone else's pockets.
GLTA...
